Last $1.27 USD
Change Today +0.12 / 10.43%
Volume 342.5K
UPI On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 8:10 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sven A. Wehrwein

Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee, Uroplasty, Inc.
AgeTotal Calculated CompensationThis person is connected to 31 board members in 7 different organizations across 11 different industries.

See Board Relationships
63$73,071

Background*

Mr. Sven A. Wehrwein has been an Independent Financial Consultant to emerging companies since March 1999. Mr. Wehrwein has over 30 years experience in corporate finance and investment banking. Mr. Wehrwein has a 14-year career in investment banking for Dean Witter Reynolds. Mr. Wehrwein served as the Chief Financial Officer of Digi International Inc. from December 1998 to February 1999 and Center for Diagnostic Imaging from November 1997 to July 1998. He served as Chief ...

Read Full Background

Corporate Headquarters*

5420 Feltl Road
Minnetonka, Minnesota 55343

United States

Phone: 952-426-6140
Fax: 952-426-6199

Board Members Memberships*

Independent Director and Member of Audit Committee
Independent Director and Member of Audit Committee
Former Independent Director and Member of Audit Committee
Director and Member of Audit Committee
1997-2011
Former Independent Director, Chairman of Audit Committee and Member of Compensation Committee
1999-Present
Director and Chairman of Audit Committee
2004-2012
Former Independent Director, Chairman of Audit Committee and Member of Governance Committee
2006-N/A
Former Director, Chairman of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation & Stock Option Committee
2006-Present
Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2007-2011
Former Outside Director, Chairman of Audit Committee and Member of Compensation Committee
2008-Present
Director, Chairman of Audit Committee and Member of Governance & Nominating Committee
2008-Present
Director
2011-Present
Lead Independent Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
2014-Present
Director

Education*

MBA
MIT Sloan School of Management
BS
Loyola University of Chicago

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$38,000
Total Calculated Compensation$73,071
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UPI:US $1.27 USD +0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William C. Mills IIIChairman of the Board, Chief Executive Officer and Chairman of Strategy & Technology Committee
Stereotaxis Inc.
$370.9K
Gregory J. Fluet Chief Executive Officer, Interim Chief Financial Officer and Director
Urologix, Inc.
$200.0K
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Howard Zauberman Chief Executive Officer, President and Director
Vision-Sciences Inc.
$210.9K
Daniel Goldberger Chief Executive Officer and Director
Bacterin International Holdings, Inc.
$143.1K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UROPLASTY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.